<bill session="103" type="h" number="4427" updated="2010-04-19T10:41:10-04:00">
	<state datetime="1994-05-16">REFERRED</state>
	<status><introduced datetime="1994-05-16"/></status>

	<introduced datetime="1994-05-16"/>
	<titles>
		<title type="short" as="introduced">Better Pharmaceuticals for Children Act</title>
		<title type="official" as="introduced">To amend the Federal Food, Drug, and Cosmetic Act to allow for additional deferred effective dates for approval of applications under the new drugs provisions, and for other purposes.</title>
	</titles>
	<sponsor id="406482"/>
	<cosponsors>
		<cosponsor id="411040" joined="1994-05-16"/>
		<cosponsor id="409442" joined="1994-05-16"/>
		<cosponsor id="410567" joined="1994-05-16"/>
		<cosponsor id="407153" joined="1994-10-06"/>
		<cosponsor id="408476" joined="1994-06-30"/>
		<cosponsor id="404190" joined="1994-06-30"/>
	</cosponsors>
	<actions>
		<action datetime="1994-05-16"><text>Sponsor introductory remarks on measure. (CR E935)</text></action>
		<action datetime="1994-05-16"><text>Referred to the House Committee on Energy and Commerce.</text></action>
		<action datetime="1994-06-07"><committee name="House Committee on Energy and Commerce"/><text>Referred to the Subcommittee on Health and the Environment.</text></action>
	</actions>
	<committees>
		<committee code="HSIF" name="House Energy and Commerce" activity="Referral, In Committee" />
		<committee code="" name="House Energy and Commerce" subcommittee="Health and Environment" activity="Referral" />
	</committees>
	<relatedbills>

	</relatedbills>
	<subjects>
		<term name="Drugs"/>
		<term name="Administrative procedure"/>
		<term name="Business"/>
		<term name="Child health"/>
		<term name="Children"/>
		<term name="Clinical trials"/>
		<term name="Drug industry"/>
		<term name="Executive departments"/>
		<term name="Medical care"/>
		<term name="Medicine"/>
		<term name="Pharmaceutical research"/>
		<term name="Science policy"/>
	</subjects>
	<amendments>

	</amendments>
	<summary>
	5/16/1994--Introduced.
Better Pharmaceuticals for Children Act - Amends the Federal Food, Drug, and Cosmetic Act to regulate the effective date of the approval of certain new drug applications (including abbreviated new drug applications) when pediatric studies of the drug are involved.

	</summary>
</bill>
